Dusseldorf The summer holidays in Germany’s largest federal state, North Rhine-Westphalia, started last week and we are also in the mood to travel. Therefore, in the new episode of Handelsblatt Deals, we are concentrating on five deals around the world that interested parties should keep an eye on.
There is, for example, the pharmaceutical giant Pfizer in the USA, which wants to buy the cancer specialist Seagen. Pfizer has a lot of money in the till, which the corona pandemic and the vaccine against the corona virus developed together with Biontech have brought in, among other things. Time to look around for new companies to add to your portfolio.
“This is something that can be observed again and again with big pharma companies,” says corporate finance correspondent Arno Schütze. “The patents on medicines will expire at some point and may be reproduced by generic manufacturers. The big pharma company then looks for manufacturers of other drugs that it can add to its portfolio through an acquisition.”
But sometimes deals also end: The e-commerce company Alibaba has to experience first-hand what happens when a major shareholder from the very beginning gradually withdraws. Because the investment group Softbank recently sold almost its entire stake in the Chinese online retailer. The two CEOs Jack Ma and Masayoshi Son have a long history together.
In the current episode of Handelsblatt Deals, you can find out who is currently profiting from the gold boom, which deals almost took place in Germany instead of in the USA and which deals are still important internationally.
If you have any comments, questions, criticism or praise for this episode, please feel free to email us: [email protected]
Exclusive offer for Handelsblatt Deals listeners: Test Handelsblatt Premium for 4 weeks for €1 and stay informed about what’s happening in the business world. More information: handelsblatt.com/mehrfusionen.
Help us to keep improving our podcasts. Your opinion is important to us: www.handelsblatt.com/satisfaction